| Particulars |
|
|
|
| Company Name
| Procter & Gamble Health Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
16.60 |
B.V. (₹) |
373.30 |
| Sales(₹ Cr.) |
934.17 |
NP (₹ Cr.) |
234.51 |
| NP Var% |
9.00 |
Div% |
1,250.00 |
| CPS(₹) |
151.30 |
EPS (₹) |
141.30 |
| Traded Value(₹ Lakhs) |
28.57 |
52 Week High |
6,700.00 |
| 52 Week Low |
4,700.00 |
Price BSE |
4,814.00 |
| Price NSE |
4,822.00 |
Market Capital (₹ Cr.) |
7,990.36 |
| P/C Ratio |
31.80 |
P/E Ratio |
34.10 |
| Price Vs.BV |
12.90 |
|
| Latest Quarter |
| Year End |
202512 |
Sales (₹ Cr.) |
373.86 |
| NP(₹ Cr.) |
77.59 |
NP Var % |
-15.00 |
| Trailing Twelve Months |
| Year End |
202512 |
Sales |
1,159.74 |
| OPM |
26.83 |
NP |
226.62 |
| NP Var% |
|
EPS |
176.81 |
| PE |
27.22 |
|
|